Skip to main content
. 2018 Nov 28;39:377–387. doi: 10.1016/j.ebiom.2018.11.040

Fig. 4.

Fig. 4

Active GSK3β does not impact KA-induced seizures in vivo in the first 24 h after administration. Quantification of the (a) average number of seizures per day, (b) average seizure duration, and (c) average seizure score in first the 24 h post-KA in wildtype (n = 7) and GSK3β[S9A] (n = 7) mice (unpaired t-test).